Detalhe da pesquisa
1.
Second hematopoietic stem cell transplantation as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndromes after a first transplantation.
Haematologica
; 108(7): 1782-1792, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36475520
2.
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients.
Br J Haematol
; 196(4): 884-891, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34713441
3.
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study.
Ann Hematol
; 101(2): 379-387, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34628534
4.
A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia.
Eur J Haematol
; 106(2): 260-266, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33159365
5.
Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.
Acta Haematol
; 144(6): 613-619, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102632
6.
Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation.
Eur J Haematol
; 103(4): 402-409, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31332836
7.
Isolated Extramedullary Relapse of Acute Leukemia after Allogeneic Stem Cell Transplantation: Different Kinetics and Better Prognosis than Systemic Relapse.
Biol Blood Marrow Transplant
; 23(7): 1087-1094, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28396161
8.
The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors.
Am J Hematol
; 92(3): 259-268, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28052467
9.
Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.
Am J Hematol
; 92(10): 1011-1019, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28631269
10.
Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 22(2): 277-283, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26343949
11.
Plerixafor (Mozobil): A Stem Cell-Mobilizing Agent for Transplantation in Lymphoma Patients Predicted to Be Poor Mobilizers - A Pilot Study.
Acta Haematol
; 135(1): 29-36, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26303343
12.
Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia.
Cancer
; 121(6): 863-71, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25387866
13.
Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation.
Ann Hematol
; 94(3): 375-8, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25307457
14.
Liver stiffness measurements predict Sinusoidal Obstructive Syndrome after hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658660
15.
Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study.
Bone Marrow Transplant
; 59(3): 409-416, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212672
16.
Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphoma.
Leuk Lymphoma
; 64(12): 1956-1963, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37565578
17.
Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma.
Transplant Cell Ther
; 29(2): 99-107, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36343892
18.
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma.
Leukemia
; 37(1): 154-163, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335261
19.
Anti-T lymphocyte globulin (ATG) induces generation of regulatory T cells, at least part of them express activated CD44.
J Clin Immunol
; 32(1): 173-88, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21979414
20.
Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma.
Transplant Cell Ther
; 28(5): 251-257, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218999